Tsuneo Morishima
About
In The Last Decade
Tsuneo Morishima
227 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Epidemiology 4.0k
- Infectious Diseases 2.7k
- Oncology 1.9k
- Immunology 1.3k
- Hepatology 790
Countries citing papers authored by Tsuneo Morishima
This map shows the geographic impact of Tsuneo Morishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsuneo Morishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsuneo Morishima more than expected).
Fields of papers citing papers by Tsuneo Morishima
This network shows the impact of papers produced by Tsuneo Morishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsuneo Morishima. The network helps show where Tsuneo Morishima may publish in the future.
Co-authorship network of co-authors of Tsuneo Morishima
This figure shows the co-authorship network connecting the top 25 collaborators of Tsuneo Morishima. A scholar is included among the top collaborators of Tsuneo Morishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsuneo Morishima. Tsuneo Morishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 4 | |
| 3 | 17 | |
| 4 | 9 | |
| 5 | 62 | |
| 6 | 1 | |
| 7 | 31 | |
| 8 | The Study of Forty Six Patients with Maladaptive Eating Behaviors and the Role of Pediatrician | 1 |
| 9 | 11 | |
| 10 | 6 | |
| 11 | Epidemiologic Survey of Influenza-associated Complications : II. A Statistical Analysis of Symptoms and Signs, and Medication | 10 |
| 12 | 5 | |
| 13 | 10 | |
| 14 | 166 | |
| 15 | 140 | |
| 16 | ADOPTIVE IMMUNE THERAPY FOR EB VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS | 1 |
| 17 | 6 | |
| 18 | 8 | |
| 19 | 9 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.